Font Size:
a
A
A
Keyword [Human Epidermal Growth Factor Receptor 2]
Result: 61 - 80 | Page: 4 of 5
61.
The Application Study Of Liquid Biopsy In The Individualized Therapy Of HER2 Positive Breast Cancer Patients
62.
The Exploratory Study Of Trastuzumab Resistant Mechanism In Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Using Circulating Tumor Cells
63.
The Novel Method For In Situ Imaging Of HER2 Protein On Breast Cancer Cell Surface Based On Proximity Effect
64.
Multiparametric MRI-based Radiomics Model For Predicting HER-2 2+status Of Breast Cancer And HER-2 Positive Breast Cancer Under Different Status Of HR
65.
The Role And Mechanism Study Of Human Epidermal Growth Factor Receptor 2(HER2) In Arsenic-induced Bladder Epithelial Cell Malignant Transformation
66.
Expression Of HER-2 And Disease Characteristics In 248 Cases Of Urothelial Carcinoma
67.
Characteristics And Clinical Significance Of Microenvironmental Immune Cells In HER-2 Positive Gastric Cancer
68.
Preparation Of Targeted Lipid Nano Ultrasound Contrast Agents With HSV-TK Suicide Gene And Its Target-finding Experiments In Vitro
69.
Effect Of Neoadjuvant Chemotherapy On Molecular Typing And Prognosis Of Breast Cancer
70.
Analysis Of Ultrasonic Multimodal Features Of Breast Cancer With Different HER-2 Expression
71.
Prognostic Analysis Of 311 Patients With Early HER2-Positive Breast Cancer
72.
Predictive Value Of HER2 Protein Expression Level In Pat Ients With HER2-positive Breast Cancer Receiving Neoadj Uvant Therapy
73.
Comparisons Of Efficacy And Safety Of Different Second-line Treatments For Trastuzumab-resistant Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
74.
Clinical Pathological Practicing Analysis Of HER2 FISH Detection In Breast Cancer By2018 ASCO/CAP Updated Guidelines
75.
Molecular Targeted Combination Therapy For Human Epidermal Growth Factor Receptor 2-positive / Hormone Receptor Positive Advanced Breast Cancer: A Meta-analysis
76.
The Presence Of Calcification In Breast Cancer:Influence On The Response To Neoadjuvant Chemotherapy
77.
Biomarkers For Predicting Postoperative Prognosis And Chemotherapeutic Benefits In Resectable Gastric Cancer Patients Based On The Standardized Cohorts
78.
Influencing Factors And Predictors Of Effect Of Pathological Complete Response Of HER2-positive Breast Cancer Treated With Neoadjuvant Treatment And Mechanism Of Drug Resistance
79.
The Value Of Predicting Human Epidermal Growth Factor Receptor 2 Status In Adenocarcinoma Of The Esophagogastric Junction In Different Models Of CT-based Radiomics
80.
Association Between Serum HER2/ErbB2 Levels And Risk Of Coronary Artery Disease
<<First
<Prev
Next>
Last>>
Jump to